Clinical Trial Update: IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating preoperative rectal cancer treatment using IMRT-SIB radiotherapy in combination with capecitabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Rectal Carcinoma | Phase 2 | Status: UNKNOWN